![]() |
![]() |
![]() |
|||||||
![]() ![]() ![]() ![]() |
|||||||||
![]() |
| ||||||||
![]() |
![]() |
![]() |
|||||||
TALLman LetteringDeveloped with support from Health CanadaMedication incidents are a leading cause of preventable adverse events. Drug name confusion, particularly because of look-alike/sound-alike (LASA) name attributes, can be a contributing factor to medication related adverse events. TALLman lettering is a method of applying upper-case lettering to sections of LASA drug names as a differentiation strategy. ![]() ![]() ![]() ![]() |
![]() |
||||||||
![]() |
![]() |
Copyright © 2000-2022 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved. Privacy. Disclaimer. |